The first quarter of 2018 report of Jianfeng Group
Release time:
2021-01-05
公司代码:600668 公司简称:尖峰集团
浙江尖峰集团股份有限公司
2018年第一季度报告正文
一、 重要提示
1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
1.2 公司全体董事出席董事会审议季度报告。
1.3 公司负责人蒋晓萌、主管会计工作负责人兰小龙及会计机构负责人(会计主管人员)吴德富保证季度报告中财务报表的真实、准确、完整。
1.4 本公司第一季度报告未经审计。
二、 公司主要财务数据和股东变化
2.1 主要财务数据
单位:元 币种:人民币
|
|
本报告期末 |
上年度末 |
本报告期末比上年度末增减(%) |
|
总资产 |
4,366,775,455.41 |
4,175,730,846.73 |
4.58 |
|
归属于上市公司股东的净资产 |
2,757,802,176.89 |
2,627,318,888.65 |
4.97 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
经营活动产生的现金流量净额 |
13,967,176.23 |
317,755.25 |
4,295.58 |
|
|
年初至报告期末 |
上年初至上年报告期末 |
比上年同期增减(%) |
|
营业收入 |
669,522,008.06 |
566,846,953.96 |
18.11 |
|
归属于上市公司股东的净利润 |
104,344,646.12 |
112,200,485.23 |
-7.00 |
|
归属于上市公司股东的扣除非经常性损益的净利润 |
98,932,514.65 |
108,827,872.82 |
-9.09 |
|
加权平均净资产收益率(%) |
3.89 |
4.57 |
减少0.68个百分点 |
|
基本每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
|
稀释每股收益(元/股) |
0.3032 |
0.3260 |
-7.00 |
非经常性损益项目和金额
单位:元 币种:人民币
|
项目 |
本期金额 |
说明 |
|
非流动资产处置损益 |
-25,888.87 |
|
|
越权审批,或无正式批准文件,或偶发性的税收返还、减免 |
|
|
|
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国家政策规定、按照一定标准定额或定量持续享受的政府补助除外 |
6,648,601.60 |
|
|
委托他人投资或管理资产的损益 |
270,624.68 |
|
|
除上述各项之外的其他营业外收入和支出 |
-166,308.37
|
|
|
少数股东权益影响额(税后) |
-196,583.34 |
|
|
所得税影响额 |
-1,118,314.23 |
|
|
合计 |
5,412,131.47 |
|
2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
单位:股
|
股东总数(户) |
27,298 |
||||||
|
前十名股东持股情况 |
|||||||
|
股东名称(全称) |
期末持股 数量 |
比例(%) |
持有有限售条件股份数量 |
质押或冻结情况 |
股东性质 |
||
|
股份状态 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
16.15 |
0 |
无 |
0 |
国有法人 |
|
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
4.99 |
0 |
无 |
0 |
未知 |
|
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
3.68 |
0 |
无 |
0 |
未知 |
|
|
香港中央结算有限公司 |
4,372,091 |
1.27 |
0 |
无 |
0 |
未知 |
|
|
刘锦春 |
3,874,269 |
1.13 |
0 |
无 |
0 |
境内自然人 |
|
|
钟以隆 |
3,584,000 |
1.04 |
0 |
无 |
0 |
境内自然人 |
|
|
苏志伟 |
3,226,848 |
0.94 |
0 |
无 |
0 |
境内自然人 |
|
|
王晓红 |
3,121,943 |
0.91 |
0 |
无 |
0 |
境内自然人 |
|
|
骆惠娟 |
2,726,200 |
0.79 |
0 |
无 |
0 |
境内自然人 |
|
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
0.78 |
0 |
无 |
0 |
未知 |
|
|
前十名无限售条件股东持股情况 |
|||||||
|
股东名称 |
持有无限售条件流通股的数量 |
股份种类及数量 |
|||||
|
种类 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
人民币普通股 |
55,564,103 |
||||
|
新余中盛恒兴投资管理合伙企业(有限合伙 |
17,158,922 |
人民币普通股 |
17,158,922 |
||||
|
新余汇恒瑞投资管理合伙企业(有限合伙) |
12,665,208 |
人民币普通股 |
12,665,208 |
||||
|
香港中央结算有限公司 |
4,372,091 |
人民币普通股 |
4,372,091 |
||||
|
刘锦春 |
3,874,269 |
人民币普通股 |
3,874,269 |
||||
|
钟以隆 |
3,584,000 |
人民币普通股 |
3,584,000 |
||||
|
苏志伟 |
3,226,848 |
人民币普通股 |
3,226,848 |
||||
|
王晓红 |
3,121,943 |
人民币普通股 |
3,121,943 |
||||
|
骆惠娟 |
2,726,200 |
人民币普通股 |
2,726,200 |
||||
|
中国工商银行股份有限公司-南方大数据100指数证券投资基金 |
2,667,200 |
人民币普通股 |
2,667,200 |
||||
|
上述股东关联关系或一致行动的说明 |
本公司第一大股东通济国投与其他上述第2名至第10名无限售条件股东之间不存在关联关系。公司未知其他9名股东之间是否存在关联关系,也未知是否属于《上市公司收购管理办法》规定的一致行动人。 |
||||||
|
表决权恢复的优先股股东及持股数量的说明 |
不适用 |
||||||
2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情况表
三、 重要事项
3.1 公司主要会计报表项目、财务指标重大变动的情况及原因
|
单位:万元 |
||||
|
资产负债表项目 |
期末数 |
期初数 |
变动幅度 |
变动原因 |
|
预付款项 |
9,726.83 |
4,610.82 |
110.96% |
主要系本报告期子公司预付货款增加所致。 |
|
应收股利 |
2,076.00 |
|
100.00% |
主要系报告期公司按被投资单位天士力控股集团有限公司2017年度利润分配的股东会决议计入应收的现金股利所致。 |
|
其他应收款 |
1,997.52 |
1,308.75 |
52.63% |
主要系报告期公司及子公司存出保证金增加所致。 |
|
其他流动资产 |
925.10 |
1,328.92 |
-30.39% |
主要系报告期子公司抵扣了上年取得的留抵进项税所致。 |
|
短期借款 |
16,800.00 |
8,900.00 |
88.76% |
主要系报告期公司银行贷款增加所致。 |
|
应付职工薪酬 |
1,279.67 |
3,627.55 |
-64.72% |
主要系报告期公司及子公司发放上年末计提的年终奖所致。 |
|
应付利息 |
1,579.21 |
934.17 |
69.05% |
主要系报告期公司计提应付债券利息以及由于银行借款增加相应计提利息增加所致。 |
|
应付股利 |
2,520.16 |
120.16 |
1997.38% |
主要系报告期子公司股东会决议已宣告发放2017年度现金股利所致。 |
|
利润表项目 |
本期数 |
上年同期数 |
变动幅度 |
变动原因 |
|
税金及附加 |
551.67 |
336.88 |
63.76% |
主要系报告期子公司应交税费增加所致。 |
|
销售费用 |
10,678.03 |
4,772.03 |
123.76% |
主要系报告期子公司尖峰药业销售收入的增长和销售模式的调整,公司销售费用中增加了市场推广费和其他支出。 |
|
投资收益 |
1,950.22 |
6,087.10 |
-67.96% |
主要系报告期公司联营投资单位天士力控股集团有限公司利润大幅减少,公司权益法核算计入投资收益相应减少所致。 |
|
其他收益 |
502.73 |
0.00 |
100.00% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助从“营业外收入”科目转入所致。 |
|
营业外收入 |
171.06 |
485.84 |
-64.79% |
主要系本报告期公司按新会计准则要求将与公司日常活动有关的政府补助转入“其他收益”项目所致。 |
|
营业外支出 |
27.23 |
4.66 |
483.87% |
主要系报告期子公司营业外支出增加所致。 |
|
所得税费用 |
3,098.44 |
1,981.63 |
56.36% |
主要系本报告期子公司实现的利润总额增加相应的所得税费用增加所致。 |
|
现金流量表项目 |
|
|
|
|
|
经营活动产生的现金流量净额 |
1,396.72 |
31.78 |
4295.58% |
主要系报告期由于公司经营活动现金流入增加所致。 |
|
投资活动产生的现金流量净额 |
-9,823.08 |
-2,287.17 |
|
主要系报告期子公司对外投资及在建项目投入增加所致。 |
|
筹资活动产生的现金流量净额 |
7,779.59 |
-210.06 |
|
主要系报告期公司增加了银行借款所致。 |
3.2 重要事项进展情况及其影响和解决方案的分析说明
1、2017年2月28日,公司九届10次董事会通过了《关于子公司对外投资的议案》,公司控股子公司尖峰药业拟以增资和股权转让的方式分期对北慧生物进行投资;2018年3月31日,公司披露了对外投资进展情况。上述事项详见2017年3月1日、2018年3月31日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2017-003《关于子公司对外投资的公告》、临2018-003《关于子公司对外投资的进展公告》。
2、2018年1月19日,本公司十届2次董事会通过了《关于子公司尖峰药业对外投资的议案》,尖峰药业拟投资11132.79万元以收购股份和增资的方式对上海北卡进行投资。投资完成后,上海北卡注册资本由原来的1100万元增加至1755.55万元,其中尖峰药业占55%。上述事项详见2018年1月20日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-002《关于子公司尖峰药业对外投资的公告》。截止报告期末,尖峰药业已经按照协议约定,支付了第一期股权转让款和增资款。目前正在办理资产交接、工商变更登记手续。
3、2017年4月15日,公司九届11次董事会通过了《关于尖峰国贸新建仓库(电商物流园)项目的议案》,批准控股子公司尖峰国贸投资7500万元新建仓库(电商物流园)。2017年6月6日,公司九届13次董事会通过了《关于尖峰国贸仓库出租的议案》,同意尖峰国贸将该新建仓库(电商物流园)的仓库、堆场、停车场等物业出租给上海安能聚创供应链管理有限公司。上述事项详见2017年4月18日、2017年6月7日披露于上海证券交易所网站(http//:www.sse.com.cn/) 的临2017-006《九届11次董事会决议公告》和临2017-013《九届13次董事会决议公告》。截止3月底,该项目累计已投入资金3909.65万元。
3.3 报告期内超期未履行完毕的承诺事项
3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警示及原因说明
|
公司名称 |
浙江尖峰集团股份有限公司 |
|
法定代表人 |
蒋晓萌 |
|
日期 |
2018年4月27日 |
- 发布时间: 2018-04-28
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31